Benefit of nectin-4 targeting with enfortumab vedotin confirmed.
作者信息
Romero Diana
机构信息
Chief Editor, Nature Reviews Clinical Oncology, .
出版信息
Nat Rev Urol. 2021 Apr;18(4):190. doi: 10.1038/s41585-021-00449-1.
PMID:33692500
Abstract
摘要
Romero Diana
Chief Editor, Nature Reviews Clinical Oncology, .
Nat Rev Urol. 2021 Apr;18(4):190. doi: 10.1038/s41585-021-00449-1.
Zotero 插件